Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.6903
-0.0497 (-6.72%)
Apr 29, 2026, 10:49 AM EDT - Market open
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $33.55 million as of April 29, 2026. Its market cap has increased by 5.40% in one year.
Market Cap
33.55M
Enterprise Value
-11.65M
1-Year Change
5.40%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $33.55M, a decrease of -92.38%. That is a compound annual growth rate of -40.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 35.96M | 16.95% |
| Dec 31, 2025 | 30.75M | -53.38% |
| Dec 31, 2024 | 65.95M | -52.79% |
| Dec 29, 2023 | 139.70M | 121.66% |
| Dec 30, 2022 | 63.03M | -80.81% |
| Dec 31, 2021 | 328.47M | -25.42% |
| Apr 30, 2021 | 440.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lixte Biotechnology Holdings | 43.10M |
| Lite Strategy | 42.91M |
| Sensei Biotherapeutics | 42.61M |
| Atara Biotherapeutics | 40.97M |
| Actinium Pharmaceuticals | 39.91M |
| Aligos Therapeutics | 39.60M |
| RenovoRx | 38.59M |
| NextCure | 37.46M |